Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.

BACKGROUND Postthrombotic syndrome (PTS) is a frequent, chronic complication of DVT. The effectiveness and safety of available treatments are unknown. The objective of this study was to systematically review the literature to assess whether pharmacologic and compression therapies are effective and safe for the treatment of PTS. METHODS We sought to identify randomized controlled trials (RCTs) via a search of PubMed, studies referenced in included publications, and studies that cited relevant literature. RESULTS A total of 121 titles were reviewed, 12 full-text publications were assessed for inclusion, and seven RCTs, including 703 patients, were selected for inclusion. Four trials assessed the effectiveness of drugs, including rutosides, hidrosmin, and defibrotide, and four trials assessed compression therapies for treatment of PTS. Systems for the diagnosis and classification of PTS severity varied across studies. Three of four drug therapy trials reported moderate improvement in selected PTS symptoms, minor changes in calf and ankle circumference, and some effects on ulcer healing. Two studies of compression stockings did not report benefit. Two studies that assessed compression devices reported improvement in PTS symptoms scores; one of these reported an improvement in quality-of-life score. CONCLUSIONS There is limited and low-quality evidence for the effectiveness of rutosides, hidrosmin, defibrotide, and compression stockings, but moderate-quality evidence that supports the use of intermittent compression to provide at least short-term relief from PTS. More rigorous studies are needed to assess the short- and long-term effectiveness and safety of PTS therapies.

[1]  Gordon H Guyatt,et al.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.

[2]  G. Guyatt,et al.  GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.

[3]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[4]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[5]  P. Prandoni,et al.  Post‐thrombotic syndrome: prevalence, prognostication and need for progress , 2009, British journal of haematology.

[6]  P. Prandoni,et al.  Definition of post‐thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization , 2009, Journal of thrombosis and haemostasis : JTH.

[7]  J. Heit,et al.  Incidence and cost burden of post-thrombotic syndrome , 2009, Journal of Thrombosis and Thrombolysis.

[8]  D. Lamping,et al.  Determinants of health‐related quality of life during the 2 years following deep vein thrombosis , 2008, Journal of thrombosis and haemostasis : JTH.

[9]  M. O’Donnell,et al.  Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) , 2008, Thrombosis and Haemostasis.

[10]  Jay Lin,et al.  Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[11]  D. Lamping,et al.  VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. , 2006, Journal of clinical epidemiology.

[12]  S. Kahn,et al.  Comparison of the Villalta and Ginsberg clinical scales to diagnose the post‐thrombotic syndrome: correlation with patient‐reported disease burden and venous valvular reflux , 2006, Journal of thrombosis and haemostasis : JTH.

[13]  P. Prandoni,et al.  Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome , 2005, Thrombosis and Haemostasis.

[14]  G. Gensini,et al.  Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study. , 2004, International angiology : a journal of the International Union of Angiology.

[15]  S. Schroter,et al.  Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. , 2003, Journal of vascular surgery.

[16]  C. Pashos,et al.  Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  M Gent,et al.  Prevention and treatment of postphlebitic syndrome: results of a 3-part study. , 2001, Archives of internal medicine.

[18]  M. Gent,et al.  Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[19]  D. Bergqvist,et al.  Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden , 1997, Annals of Internal Medicine.

[20]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[21]  Gregory L. Moneta,et al.  Reporting standards in venous disease: An update , 1995 .

[22]  C. Lisbona,et al.  A Prospective Study of the Long-Term Efficacy of Two Different Venoactive Drugs in Patients with Post-Thrombotic Syndrome , 1994 .

[23]  J. T. ten Cate,et al.  A Double Blind Three Center Clinical Trial on the Short-Term Efficacy of 0-(β-Hydroxyethyl)-Rutosides in Patients with Post-Thrombotic Syndrome , 1989, Thrombosis and Haemostasis.

[24]  D. Lawrence,et al.  Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study. , 1985, American journal of surgery.

[25]  Erik Svensjö,et al.  Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin. , 1983, International journal of microcirculation, clinical and experimental.